Ledger.Open graph →
SEC Form D · filed October 17, 2013

G1 Therapeutics, Inc

Offering
$12.6M
Sold
$6.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHAPEL HILL, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Christy Shaffer · Chapel Hill, NCDirectorClay Thorp · Nashville, TNDirectorJay Strum · Chapel Hill, NCExec · DirectorChristy Shaffer · Research Triangle Park, NCDirectorNorman Sharpless · Chapel Hill, NCDirectorClay Thorp · Malvern, PADirectorCarol Webb · Chapel Hill, NCDirectorThomas K. Laundon · Chapel Hill, NCExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗